drugset / Trial / NCT05636826

Olive Leaf Extracts in the Control of Hypertension

NCT05636826 ↗

Phase 2/3 Completed 500 enrolled University of Monastir
RandomizedParallel-groupSingle-blindTreatment

Summary

This study will be carried out in 2 emergency departments (at the exit of the emergency room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal hospital). Patients over 18 years of age with: Arterial hypertension (hypertension).

Timeline

Start
2023-12-30
Primary completion
2024-11-22
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atherolive Unknown 400 mg —

Indications